Get started
Author

Barbara Beghetto

Observed names: B Beghetto, B. Beghetto, Beghetto Barbara, Beghetto, Barbara
ORCID: 0000-0002-1072-872X
Observed ORCID: 0000-0002-1072-872X
OpenAlex ID: A5002665717
Aging with HIV vs. HIV Seroconversion at Older Age: A Diverse Population with Distinct Comorbidity Profiles
2015 · Giovanni Guaraldi, Stefano Zona, et al. · PLoS ONE · 111
Multidisciplinary Approach to the Treatment of Metabolic and Morphologic Alterations of HIV-Related Lipodystrophy
2006 · Giovanni Guaraldi, Gabriella Orlando, et al. · HIV Clinical Trials · 57
PDF
Quality of Life and Body Image in the Assessment of Psychological Impact of Lipodystrophy: Validation of the Italian Version of Assessment of Body Change and Distress Questionnaire
2006 · G. Guaraldi, G. Orlando, et al. · Quality of Life Research · 53
Severity of Lipodystrophy Is Associated with Decreased Health-Related Quality of Life
2008 · Giovanni Guaraldi, Rita Murri, et al. · AIDS Patient Care and STDs · 51
Burden of Disease in PWH Harboring a Multidrug-Resistant Virus: Data From the PRESTIGIO Registry
2020 · Laura Galli, Maria Rita Parisi, et al. · Open Forum Infectious Diseases · 50
PDF
Immediate Versus Deferred Switching From a Boosted Protease Inhibitor–based Regimen to a Dolutegravir-based Regimen in Virologically Suppressed Patients With High Cardiovascular Risk or Age ≥50 Years: Final 96-Week Results of the NEAT022 Study
2018 · José M Gatell, Lambert Assoumou, et al. · Clinical Infectious Diseases · 49
PDF
Morphologic Alterations in HIV-Infected People with Lipodystrophy Are Associated with Good Adherence to HAART
2003 · Guaraldi Giovanni, Murri Rita, et al. · HIV Clinical Trials · 46
PDF
Detectable HIV Viral Load Is Associated With Metabolic Syndrome
2009 · Nicola Squillace, Stefano Zona, et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 45
The natural history of HIV ‐associated lipodystrophy in the changing scenario of HIV infection
2014 · G Guaraldi, C Stentarelli, et al. · HIV Medicine · 32
Switching from boosted PIs to dolutegravir decreases soluble CD14 and adiponectin in high cardiovascular risk people living with HIV
2021 · Ana González-Cordón, Lambert Assoumou, et al. · Journal of Antimicrobial Chemotherapy · 27
Prediction of hard cardiovascular events in HIV patients
2016 · Paolo Raggi, Davide De Francesco, et al. · Journal of Antimicrobial Chemotherapy · 26
Long-Term Psychometric Outcomes of Facial Lipoatrophy Therapy: Forty-Eight–Week Observational, Nonrandomized Study
2007 · G. Orlando, G. Guaraldi, et al. · AIDS Patient Care and STDs · 26
Evaluating immunological and inflammatory changes of treatment-experienced people living with HIV switching from first-line triple cART regimens to DTG/3TC vs. B/F/TAF: the DEBATE trial
2023 · Andrea Cossarizza, Alessandro Cozzi-Lepri, et al. · Frontiers in Immunology · 21
Prevalence of and Risk Factors for Pubic Lipoma Development in HIV-Infected Persons
2007 · Giovanni Guaraldi, Gabriella Orlando, et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 21
Limited Weight Impact After Switching From Boosted Protease Inhibitors to Dolutegravir in Persons With Human Immunodeficiency Virus With High Cardiovascular Risk: A Post Hoc Analysis of the 96-Week NEAT-022 Randomized Trial
2022 · Laura Waters, Lambert Assoumou, et al. · Clinical Infectious Diseases · 17
PDF
18Fluoride-based molecular imaging of coronary atherosclerosis in HIV infected patients
2020 · Giovanni Guaraldi, Jovana Milic, et al. · Atherosclerosis · 15
Randomized Trial to Evaluate Cardiometabolic and Endothelial Function in Patients with Plasma HIV-1 RNA Suppression Switching to Darunavir/Ritonavir with or without Nucleoside Analogues
2013 · G. Guaraldi, S. Zona, et al. · HIV Clinical Trials · 15
PDF
Effects of atazanavir, darunavir, and raltegravir on fat and muscle among persons living with HIV
2020 · Stefan Adrian, Hongyu Miao, et al. · HIV Research & Clinical Practice · 13
Successful Pre- and Posttransplant Sofosbuvir-Based Anti-Hepatitis C Virus Treatment in Persons Living With Human Immunodeficiency Virus Infection
2017 · Giovanni Guaraldi, Roberto Rossotti, et al. · Open Forum Infectious Diseases · 9
PDF
Polypharmacy, anticholinergic burden and drug–drug interaction assessment in people with four-class-resistant HIV: data from the PRESTIGIO registry
2024 · Maria Mazzitelli, Domenico Pontillo, et al. · Journal of Antimicrobial Chemotherapy · 8
Use of next-generation sequencing on HIV-1 DNA to assess archived resistance in highly treatment-experienced people with multidrug-resistant HIV under virological control: data from the PRESTIGIO Registry
2024 · Daniele Armenia, Vincenzo Spagnuolo, et al. · Journal of Antimicrobial Chemotherapy · 7
Switching from boosted PIs to dolutegravir in HIV-infected patients with high cardiovascular risk: 48 week effects on subclinical cardiovascular disease
2020 · Ana Gonzalez-Cordon, Lambert Assoumou, et al. · Journal of Antimicrobial Chemotherapy · 7
Weight Gain during Pregnancy in Women with HIV Receiving Different Antiretroviral Regimens
2019 · Marco Floridia, Giulia Masuelli, et al. · Antiviral Therapy · 7
Hepatitis C virus antibody‐positive patients with HIV infection have a high risk of insulin resistance: a cross‐sectional study
2008 · N Squillace, G Lapadula, et al. · HIV Medicine · 6
Atazanavir and darunavir in pregnant women with HIV: evaluation of laboratory and clinical outcomes from an observational national study
2017 · M Floridia, G Masuelli, et al. · Journal of Antimicrobial Chemotherapy · 5
PDF
Works count: 91
Citation count: 754
H-index: 15
I10-index: 18
Year
Topic
Type